5232 Organometallics, Vol. 22, No. 25, 2003
Cadierno et al.
3
2.94 (m, 2H each, CH(CH3)2), 3.72 (d, 2H, J HH ) 4.9 Hz,
the limited series of efficient catalysts containing ligands
with no N-H functionalities. As it is well-known, the
presence of an NH group is required to achieve efficient
ketone transfer hydrogenations.17b,d,f,g,27 The synthesis
of related dimers containing optically active diphos-
phines to use in asymmetric catalysis is currently in
progress.
CHH(syn)), 4.36 (br, 6H, C5H4), 4.69 (m, 1H, CH), 4.81 (br, 2H,
C5H4) ppm. 13C{1H} NMR (CD2Cl2): δ 19.69, 20.25, 20.60, and
21.08 (s, CH(CH3)2), 30.21 and 30.52 (d, J CP ) 19.3 Hz, CH-
(CH3)2), 55.62 (m, CH2), 70.69, 71.69, 73.98, and 75.51 (br, CH
of C5H4), 82.31 (d, J CP ) 34.2 Hz, C of C5H4), 98.64 (s, CH),
204.45 (t, J CP ) 15.3 Hz, CO) ppm. 3b: yield 82% (0.548 g).
1
1
2
Anal. Calcd for FeRuC26H41P2BrO: C, 46.73; H, 6.18. Found:
C, 46.51; H, 6.29. IR (KBr, cm-1): ν 1911 (CtO). 31P{1H} NMR
Exp er im en ta l Section
(CD
2Cl2): δ 40.74 (s) ppm. 1H NMR (CD2Cl2): δ 1.32 (m, 24H,
3
3
CH(CH3)2), 2.32 (dd, 2H, J HH ) 12.5 Hz, J HP ) 5.3 Hz,
The manipulations were performed under an atmosphere
of dry nitrogen using vacuum-line and standard Schlenk
techniques. Solvents were dried by standard methods and
distilled under nitrogen before use. All reagents were obtained
from commercial suppliers and used without further purifica-
tion with the exception of compounds [RuX(η3-2-C3H4R)(CO)3]
(R ) H, X ) Cl (1a ),10a Br (1b);10a R ) Me, X ) Cl (1c),10a Br
(1d )10b) and [Fe(η5-C5H4PR2)2] (R ) Ph (dppf),28 iPr (dippf)29),
which were prepared by following the methods reported in the
literature. Infrared spectra were recorded on a Perkin-Elmer
1720-XFT spectrometer. The C, H, and N analyses were
carried out with a Perkin-Elmer 2400 microanalyzer. NMR
spectra were recorded on a Bruker DPX-300 instrument at 300
MHz (1H), 121.5 MHz (31P), or 75.4 MHz (13C) using SiMe4 or
85% H3PO4 as standard. DEPT experiments have been carried
out for all the compounds reported. Abbreviations used: s,
singlet; br, broad singlet; d, doublet; dd, doublet of doublets;
t, triplet; m, multiplet.
CHH(anti)), 2.44 and 2.94 (m, 2H each, CH(CH3)2), 3.71 (dd, 2H,
3
3J HH ) 5.3 Hz, J HP ) 2.0 Hz, CHH(syn)), 4.36 (br, 6H, C5H4),
4.69 (m, 1H, CH), 4.80 (br, 2H, C5H4) ppm. 13C{1H} NMR (CD2-
Cl2): δ 19.69, 20.25, 20.61, and 21.08 (s, CH(CH3)2), 30.21 and
1
30.51 (d, J CP ) 19.5 Hz, CH(CH3)2), 55.62 (m, CH2), 70.70,
1
71.09, 73.99, and 75.51 (br, CH of C5H4), 82.30 (d, J CP ) 34.6
2
Hz, C of C5H4), 98.63 (s, CH), 204.45 (t, J CP ) 15.3 Hz, CO)
ppm.
Syn th esis of [Ru X(η3-2-C3H4Me)(CO)(P kP )] (P kP
)
d p p f, X ) Cl (2c), Br (2d ); P kP ) d ip p f, X ) Cl (3c), Br
(3d )). Gen er a l P r oced u r e. The corresponding diphosphine
(1 mmol) was added at room temperature to a solution of [RuX-
(η3-2-C3H4Me)(CO)3] (1c,d ) (1 mmol) in 30 mL of tetrahydro-
furan. The reaction mixture was heated under reflux for 2 h
(3c,d ) or 7 h (2c,d ) and then evaporated to dryness. The solid
residue was dissolved in dichloromethane (ca. 3 mL) and the
resulting solution transferred to an Al2O3 (neutral; activity
grade I) chromatography column. Elution with methanol gave
a yellow-orange band, from which complexes 2c,d and 3c,d
were obtained by solvent removal. 2c: yield 75% (0.581 g).
Anal. Calcd for FeRuC39H35P2ClO: C, 60.52; H, 4.56. Found:
C, 60.37; H, 4.43. IR (KBr, cm-1) ν 1921 (CtO). 31P{1H} NMR
Syn t h esis of [R u X(η3-C3H 5)(CO)(P kP )] (P kP ) d p p f,
X ) Cl (2a ), Br (2b); P kP ) d ip p f, X ) Cl (3a ), Br (3b)).
Gen er al P r ocedu r e. The corresponding diphosphine (1 mmol)
was added at room temperature to a solution of [RuX(η3-C3H5)-
(CO)3] (1a ,b) (1 mmol) in 30 mL of toluene. The reaction
mixture was heated under reflux for 40 min (3a ,b) or 3 h (2a ,b)
and then evaporated to dryness. The solid residue was dis-
solved in dichloromethane (ca. 3 mL) and the resulting solution
transferred to an Al2O3 (neutral; activity grade I) chromatog-
raphy column. Elution with methanol gave a yellow-orange
band, from which complexes 2a ,b and 3a ,b were obtained by
solvent removal. 2a : yield 75% (0.570 g). Anal. Calcd for
FeRuC38H33P2ClO: C, 60.06; H, 4.38. Found: C, 59.85; H, 4.13.
IR (KBr, cm-1): ν 1926 (CtO). 31P{1H} NMR (CD2Cl2): δ 34.31
1
(CD2Cl2): δ 35.45 (s) ppm. H NMR (CD2Cl2): δ 2.06 (s, 3H,
3
CH3), 2.11 (d, 2H, J HP ) 5.1 Hz, CHH(anti)), 3.57 (s, 2H,
CHH(syn)), 4.18, 4.39, 4.55 and 5.41 (br, 2H each, C5H4), 7.25-
7.65 (m, 20H, Ph) ppm. 13C{1H} NMR (CD2Cl2): δ 26.19 (s,
CH3), 59.52 (m, CH2), 72.06, 72.28, 75.08, and 76.32 (br, CH
1
of C5H4), 82.51 (d, J CP ) 45.1 Hz, C of C5H4), 118.94 (s, C),
2
127.15-138.40 (m, Ph), 204.55 (t, J CP ) 15.0 Hz, CO) ppm.
2d : yield 76% (0.622 g). Anal. Calcd for FeRuC39H35P2BrO:
C, 57.23; H, 4.31. Found: C, 57.42; H, 4.70. IR (KBr, cm-1): ν
1920 (CtO). 31P{1H} NMR (CD2Cl2): δ 35.27 (s) ppm. 1H NMR
3
(s) ppm. 1H NMR (CD2Cl2): δ 2.09 (dd, 2H, J HH ) 8.9 Hz,
3J HP ) 5.0 Hz, CHH(anti)), 3.69 (d, 2H, 3J HH ) 5.8 Hz, CHH(syn)),
4.20, 4.39, 4.55 and 5.40 (br, 2H each, C5H4), 4.91 (m, 1H, CH),
7.30-7.65 (m, 20H, Ph) ppm. 13C{1H} NMR (CD2Cl2): δ 58.80
(m, CH2), 72.05, 72.34, 75.14, and 76.39 (br, CH of C5H4), 82.54
3
(CD2Cl2): δ 2.12 (s, 3H, CH3), 2.18 (d, 2H, J HP ) 5.6 Hz,
CHH(anti)), 3.63 (s, 2H, CHH(syn)), 4.24, 4.45, 4.61, and 5.47 (br,
2H each, C5H4), 7.30-7.70 (m, 20H, Ph) ppm. 13C{1H} NMR
(CD2Cl2): δ 25.89 (s, CH3), 59.23 (m, CH2), 71.76, 71.99, 74.77,
and 76.02 (br, CH of C5H4), 82.23 (d, 1J CP ) 43.6 Hz, C of C5H4),
1
(d, J CP ) 45.0 Hz, C of C5H4), 101.28 (s, CH), 127.25-138.55
2
(m, Ph), 202.98 (t, J CP ) 14.3 Hz, CO) ppm. 2b: yield 80%
2
118.65 (s, C), 127.00-138.15 (m, Ph), 204.26 (t, J CP ) 14.2
(0.644 g). Anal. Calcd for FeRuC38H33P2BrO: C, 56.74; H, 4.13.
Found: C, 56.41; H, 4.02. IR (KBr, cm-1): ν 1926 (CtO). 31P-
{1H} NMR (CD2Cl2): δ 34.55 (s) ppm. 1H NMR (CD2Cl2): δ
Hz, CO) ppm. 3c: yield 69% (0.440 g). Anal. Calcd for
FeRuC27H43P2ClO: C, 50.83; H, 6.79. Found: C, 50.91; H, 6.87.
IR (KBr, cm-1): ν 1908 (CtO). 31P{1H} NMR (CD2Cl2): δ 41.08
3
3
2.07 (dd, 2H, J HH ) 12.8 Hz, J HP ) 5.1 Hz, CHH(anti)), 3.69
1
(s) ppm. H NMR (CD2Cl2): δ 1.38 (m, 24H, CH(CH3)2), 2.05
3
(d, 2H, J HH ) 7.4 Hz, CHH(syn)), 4.18, 4.39, 4.55 and 5.39 (br,
(s, 3H, CH3), 2.45 (m, 4H, CHH(anti) and CH(CH3)2), 3.04 (m,
2H, CH(CH3)2), 3.62 (s, 2H, CHH(syn)), 4.36, 4.41, 4.45, and 4.83
(br, 2H each, C5H4) ppm. 13C{1H} NMR (CD2Cl2): δ 19.41,
20.12, 20.26, and 20.88 (s, CH(CH3)2), 25.45 (s, CH3), 29.73
and 29.75 (d, 1J CP ) 21.2 Hz, CH(CH3)2), 56.65 (m, CH2), 70.43,
2H each, C5H4), 4.90 (m, 1H, CH), 7.30-7.65 (m, 20H, Ph) ppm.
13C{1H} NMR (CD2Cl2): δ 58.75 (m, CH2), 72.07, 72.35, 75.13,
and 76.36 (br, CH of C5H4), 82.46 (d, 1J CP ) 45.0 Hz, C of C5H4),
2
101.24 (s, CH), 127.25-138.50 (m, Ph), 202.99 (t, J CP ) 14.3
Hz, CO) ppm. 3a : yield 70% (0.437 g). Anal. Calcd for
FeRuC26H41P2ClO: C, 50.05; H, 6.62. Found: C, 50.12; H, 6.71.
IR (KBr, cm-1): ν 1913 (CtO). 31P{1H} NMR (CD2Cl2): δ 41.03
1
70.72, 73.38, and 75.26 (br, CH of C5H4), 82.27 (d, J CP ) 34.1
2
Hz, C of C5H4), 115.06 (s, C), 205.78 (t, J CP ) 16.1 Hz, CO)
1
ppm. 3d : yield 77% (0.525 g). Anal. Calcd for FeRuC27H43P2-
BrO: C, 47.52; H, 6.35. Found: C, 47.21; H, 6.14. IR (KBr,
cm-1): ν 1907 (CtO). 31P{1H} NMR (CD2Cl2): δ 41.04 (s) ppm.
1H NMR (CD2Cl2): δ 1.36 (m, 24H, CH(CH3)2), 2.05 (s, 3H,
CH3), 2.47 (m, 4H, CHH(anti) and CH(CH3)2), 3.03 (m, 2H,
CH(CH3)2), 3.61 (s, 2H, CHH(syn)), 4.41, 4.45, 4.51, and 4.82
(br, 2H each, C5H4) ppm. 13C{1H} NMR (CD2Cl2): δ 19.40,
20.13, 20.25, and 20.88 (s, CH(CH3)2), 25.47 (s, CH3), 29.72
and 29.74 (d, 1J CP ) 21.8 Hz, CH(CH3)2), 56.64 (m, CH2), 70.44,
(s) ppm. H NMR (CD2Cl2): δ 1.31 (m, 24H, CH(CH3)2), 2.32
3
3
(dd, 2H, J HH ) 12.2 Hz, J HP ) 4.9 Hz, CHH(anti)), 2.44 and
(26) Braunstein, P.; Naud, F.; Pfaltz, A.; Rettig, S. J . Organometal-
lics 2000, 19, 2676.
(27) Noyori, R.; Ohkuma, T. Angew. Chem., Int. Ed. 2001, 40, 40.
(28) Bishop, J . J .; Davison, A.; Katcher, M. L.; Lichtenberg, D. W.;
Merrill, R. E.; Smart, J . C. J . Organomet. Chem. 1971, 27, 241.
(29) Butler, I. R.; Cullen, W. R.; Kim, T. J . Synth. React. Inorg. Met.-
Org. Chem. 1985, 15, 109.